Search or choose
Find the right test or package.
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutation testing...
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutatio...
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutation testing helps diagnose and classify these conditions. It's also used for risk assessment in families with a history of these conditions, allowing for early intervention and personalized medical management. Additionally, targeted therapies may be considered for some in...
RET is a proto-oncogene that encodes a receptor tyrosine kinase. Mutations in the RET gene can lead to the development of certain cancers, particularly medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). RET gene mutation testing helps diagnose and classify these conditions. It's also used for risk assessment in families with a history of these conditions, allowing for early intervention and personalized medical management. Additionally, targeted therapies may be considered for some in...
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.